Precipio Inc. Announces Adjournment of Annual Meeting of Stockholders

Core Viewpoint - Precipio, Inc. convened and adjourned its 2024 Annual Meeting of Shareholders due to a lack of quorum, with plans to reconvene on June 21, 2024 [5][8]. Company Information - Precipio is a healthcare biotechnology company focused on cancer diagnostics, aiming to address cancer misdiagnoses through innovative diagnostic products and services [20]. - The company develops technologies in its laboratory to improve diagnostic outcomes and commercializes these as proprietary products for the global laboratory community [20]. Shareholder Voting Information - Shareholders as of April 19, 2024, are encouraged to vote online or by telephone, with voting open until June 20, 2024, at 11:59 p.m. Eastern Time [9][17]. - A quorum requires the presence of a majority of voting power of outstanding shares, which was not met during the initial meeting [8]. - Shareholders who have already submitted proxies do not need to vote again, as their votes will remain valid for the reconvened meeting [16].